Related Experiment Video
Updated: Oct 27, 2025
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
Antiepileptic Stiripentol May Influence Bones.
Agnieszka Matuszewska1, Beata Nowak1, Anna Nikodem2
1Department of Pharmacology, Wroclaw Medical University, ul. Jana Mikulicza-Radeckiego 2, 50-345 Wrocław, Poland.
Long-term stiripentol use in rats showed negative effects on bone health, indicated by altered vitamin D and phosphate levels. Further human studies are recommended to monitor bone health in patients on this antiepileptic drug.
Area of Science:
- Pharmacology
- Bone Biology
- Toxicology
Background:
- Chronic use of antiepileptic drugs (AEDs) is linked to bone structure abnormalities.
- Limited data exists on the skeletal effects of newer AEDs like stiripentol.
Purpose of the Study:
- To investigate the impact of long-term stiripentol administration on bone microarchitecture and serum biomarkers in a rat model.
Main Methods:
- Male Wistar rats were administered stiripentol (200 mg/kg/day) or a control solution for 24 weeks.
- Serum levels of PINP, 1,25-dihydroxyvitamin D3, inorganic phosphate, and NGAL were measured.
- Tibial microarchitecture was analyzed using micro X-ray computed tomography.
Main Results:
- Stiripentol group showed lower serum PINP at week 16.
- At week 24, the stiripentol group had lower 1,25-dihydroxyvitamin D3, higher inorganic phosphate, and higher NGAL.
- Micro CT revealed reduced bone volume fraction, thinner trabeculae, and altered trabecular pattern in the stiripentol group.
Conclusions:
- Long-term stiripentol administration may negatively affect cancellous bone microarchitecture in rats.
- Further human studies are warranted to confirm these findings.
- Monitoring vitamin D, calcium, phosphate, and kidney function is advisable for patients on long-term stiripentol therapy.
More Related Videos
08:11Construction and Use of an Electrical Stimulation Chamber for Enhancing Osteogenic Differentiation in Mesenchymal Stem/Stromal Cells In Vitro
Published on: January 31, 2019
14:31Bioelectric Analyses of an Osseointegrated Intelligent Implant Design System for Amputees
Published on: July 15, 2009
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:14Antiepileptic Drugs: Glutamate Antagonists
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...